ADDvise Group AB, founded in 2001 and headquartered in Sweden, is a leading provider of medical and laboratory equipment aimed at improving healthcare and research efficiency. The company’s key offerings include a wide range of products such as life science instruments, medical devices, and lab consumables tailored to the needs of hospitals, laboratories, and research organizations.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| ADDVSS 9.65% 2026-05-26 SEKADDvise Group AB | Sweden | 2026-05-26 | 9.647 | 4.56 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
ADDvise Group AB has been actively engaged in bond issuances since its early years, with significant milestones including a notable bond launch in 2017 to finance strategic acquisitions. Recently, the company issued a bond with a coupon rate of 3.5%, which is competitive within the industry, reflecting strong investor interest and confidence in its growth trajectory. In 2022, ADDvise successfully completed a refinancing operation that enhanced its liquidity position, showcasing resilience amidst market fluctuations, while also reinforcing its commitment to expanding its product portfolio.